Selecting optimal second-generation antihistamines for allergic rhinitis and urticaria in Asia
Abstract Background Allergic diseases are on the rise in many parts of the world, including the Asia–Pacific (APAC) region. Second-generation antihistamines are the first-line treatment option in the management of allergic rhinitis and urticaria. International guidelines describe the management of t...
Main Authors: | Marysia Tiongco Recto, Ma. Teresita Gabriel, Kanokvalai Kulthanan, Pongsakorn Tantilipikorn, Derrick Chen-Wee Aw, Tak Hong Lee, Ch’ng Chin Chwen, Somasundran Mutusamy, Nguyen Trong Hao, Vo Thanh Quang, Giorgio Walter Canonica |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-11-01
|
Series: | Clinical and Molecular Allergy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12948-017-0074-3 |
Similar Items
-
Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine
by: Wang XY, et al.
Published: (2016-04-01) -
Bilastine: A novel antihistamine
by: Jeet Gandhi, et al.
Published: (2018-01-01) -
The role and choice criteria of antihistamines in allergy management – expert opinion
by: Piotr Kuna, et al.
Published: (2016-12-01) -
Real-life experience of efficacy and safety of bilastine in the refractory cases of chronic spontaneous urticaria and its effect on the quality of life of patients
by: Abhishek De, et al.
Published: (2021-01-01) -
The safety and tolerability profile of bilastine for chronic urticaria in children
by: Nikolaos G. Papadopoulos, et al.
Published: (2019-10-01)